Diverse Effect of Inflammatory Markers on Insulin Resistance and Insulin‐Resistance Syndrome in the Elderly
Tóm tắt
Từ khóa
Tài liệu tham khảo
Albright JW, 2000, Soluble receptors and other substances that regulate proinflammatory cytokines in young and aging humans, J Gerontol A Biol Sci Med Sci, 55, 20, 10.1093/gerona/55.1.B20
Paolisso G, 1998, Advancing age and insulin resistance, Role of plasma tumor necrosis factor-α, 275, 294
Hak AE, 2001, Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly, The Rotterdam study, 86, 4398
Pickup JC, 1997, NIDDM as a disease of the innate immune system, Association of acute-phase reactants and interleukin-6 with metabolic syndrome X, 40, 1286
Alberti KG, 1998, Definition, diagnosis, and classification of diabetes mellitus and its complications, Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation, 15, 539
Friedewald WT, 1972, Estimation of serum low‐density lipoprotein without the use of a preparative ultracentrifuge, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499
Dandona P, 2002, The anti‐inflammatory and potential anti‐atherogenic effect of insulin, A new paradigm, 45, 924
Krebs DL, 2000, SOCS. Physiological suppressors of cytokine signaling, J Cell Sci, 13, 2813, 10.1242/jcs.113.16.2813
Muller‐Newman G, 1998, Soluble IL‐6 receptor potentates the antagonistic activity of soluble gp130 on IL‐6 responses, J Immunol, 161, 6347, 10.4049/jimmunol.161.11.6347
Meier C, 2002, IL‐1 receptor antagonist serum levels are increased in human obesity, A possible link to the resistance to leptin?, 87, 1184